Literature DB >> 11523587

The role of cerebral oedema in the pathogenesis of cerebral malaria.

L A Sanni1.   

Abstract

It has been suggested that sequestration of parasitized red blood cells might contribute to the pathogenesis of cerebral malaria (CM), by hypoxia causing either: (i) compensatory vasodilatation with a resultant increase in the brain volume; or (ii) enhancing cytokine-induced nitric oxide (NO) production via induction of inducible NO synthase (iNOS). Available evidence suggests that cerebral oedema is the initiating and probably the most important factor in the pathogenesis of murine CM. The relevance of this model in the study of the pathogenesis of CM has been questioned. However, a closer look at published reports on both human and murine CM, in this review, suggests that the pathogenesis of the murine model of CM might reflect more closely the CM seen in African children than that seen in Asian adults. It is also proposed that the role of iNOS induction during CM is protective: that the primary purpose of iNOS induction is to inhibit the side effects of brain indoleamine 2,3-dioxygenase (IDO) induction and quinolinic acid accumulation during hypoxia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11523587     DOI: 10.1179/135100001101536238

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  11 in total

1.  Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum.

Authors:  Samuel C Wassmer; Valéry Combes; Francisco J Candal; Irène Juhan-Vague; Georges E Grau
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Cerebral edema and cerebral hemorrhages in interleukin-10-deficient mice infected with Plasmodium chabaudi.

Authors:  Latifu A Sanni; William Jarra; Ching Li; Jean Langhorne
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

3.  Electron microscopic features of brain edema in rodent cerebral malaria in relation to glial fibrillary acidic protein expression.

Authors:  Sumate Ampawong; Urai Chaisri; Parnpen Viriyavejakul; Apichart Nontprasert; Georges E Grau; Emsri Pongponratn
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

4.  Protection against cerebral malaria by the low-molecular-weight thiol pantethine.

Authors:  Marie-France Penet; Mhamad Abou-Hamdan; Nicolas Coltel; Emilie Cornille; Georges E Grau; Max de Reggi; Bouchra Gharib
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-14       Impact factor: 11.205

5.  Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.

Authors:  Adéla Nacer; Alexandru Movila; Fabien Sohet; Natasha M Girgis; Uma Mahesh Gundra; P'ng Loke; Richard Daneman; Ute Frevert
Journal:  PLoS Pathog       Date:  2014-12-04       Impact factor: 6.823

Review 6.  Fatal cerebral malaria: a venous efflux problem.

Authors:  Ute Frevert; Adéla Nacer
Journal:  Front Cell Infect Microbiol       Date:  2014-11-06       Impact factor: 5.293

7.  Neuroimmunological blood brain barrier opening in experimental cerebral malaria.

Authors:  Adela Nacer; Alexandru Movila; Kerstin Baer; Sebastian A Mikolajczak; Stefan H I Kappe; Ute Frevert
Journal:  PLoS Pathog       Date:  2012-10-25       Impact factor: 6.823

8.  Erythropoietin treatment alleviates ultrastructural myelin changes induced by murine cerebral malaria.

Authors:  Casper Hempel; Poul Hyttel; Trine Staalsø; Jens R Nyengaard; Jørgen A L Kurtzhals
Journal:  Malar J       Date:  2012-06-28       Impact factor: 2.979

9.  Nuclear factor kappa B modulates apoptosis in the brain endothelial cells and intravascular leukocytes of fatal cerebral malaria.

Authors:  Chuchard Punsawad; Yaowapa Maneerat; Urai Chaisri; Kwannan Nantavisai; Parnpen Viriyavejakul
Journal:  Malar J       Date:  2013-07-26       Impact factor: 2.979

10.  Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity?

Authors:  Manuela Polimeni; Mauro Prato
Journal:  Fluids Barriers CNS       Date:  2014-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.